Also trades as: RGBP (OTC) · $vol 0M
RGBPP OTC
Regen BioPharma, Inc.
1W: -49.0%
1M: -51.6%
3M: -70.0%
YTD: -91.7%
1Y: -98.3%
3Y: -99.9%
5Y: -100.0%
$0.00
-0.00 (-21.05%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$237K
+0.0% ▲
5Y CAGR: +16.5%
Gross Profit
$237K
+0.0% ▲
5Y CAGR: +16.5%
Operating Income
-$339K
+19.0% ▲
Net Income
-$1M
-90.7% ▼
EPS (Diluted)
$-0.03
+76.2% ▲
EBITDA
-$339K
+18.9% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $171K | $236K | $237K | $237K | $237K |
| YoY Growth | +55.6% | +37.6% | +0.4% | +0.0% | +0.0% |
| Cost of Revenue | $25K | $50K | $0 | $0 | $90K |
| Gross Profit | $146K | $186K | $237K | $237K | $237K |
| Gross Margin | 85.4% | 78.8% | 100.0% | 100.0% | 100.0% |
| R&D Expenses | $37K | $275K | $212K | $154K | $12K |
| SG&A Expenses | $335K | $300K | $711K | $500K | $473K |
| Operating Expenses | $372K | $575K | $924K | $654K | $575K |
| Operating Income | -$201K | -$340K | -$687K | -$418K | -$339K |
| Operating Margin | -117.3% | -144.2% | -290.4% | -176.8% | -143.1% |
| Interest Expense | $367K | $255K | $59K | $247K | $210K |
| Income Before Tax | -$7M | $2M | $1M | -$668K | -$1M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$7M | $5M | $1M | -$668K | -$1M |
| Net Margin | -4166.1% | 2308.3% | 432.7% | -282.5% | -538.8% |
| EPS (Diluted) | $-0.19 | $0.15 | $0.29 | $-0.21 | $-0.03 |
| EBITDA | -$6M | $3M | $3M | -$417K | -$339K |
| Shares Outstanding | 37M | 37M | 4M | 4M | 47M |